| Followers | 96 |
| Posts | 5080 |
| Boards Moderated | 0 |
| Alias Born | 02/07/2021 |
Thursday, May 23, 2024 12:53:32 PM
I am also leaning towards voting against the options. While management made a compelling case in 14A for their many accomplishments, we need to see substantial progress this year on partnership deal to launch new trials. I want to see BP take non dilutive position in the company and provide us resources to help get this product to as many cancer patients as possible.
It's true that with Les and Linda working so hard things take longer while we wouldn't be where we are today without their leadership. Yet it simply undeniable that we need more resources to get this product on the market. I feel we could end up seeing news before the ASM which may change my mind though it's hard for me to vote yes on this matter, yet again, when our share price sits near all time lows.
Put the C shares to good use! We know the majority remain unsold.
LFG LP & LG!
Unleash the platform for all solid tumors!
It's true that with Les and Linda working so hard things take longer while we wouldn't be where we are today without their leadership. Yet it simply undeniable that we need more resources to get this product on the market. I feel we could end up seeing news before the ASM which may change my mind though it's hard for me to vote yes on this matter, yet again, when our share price sits near all time lows.
Put the C shares to good use! We know the majority remain unsold.
LFG LP & LG!
Unleash the platform for all solid tumors!
Do your own research. I am not providing legal or investment advice. Nothing I say should be considered solicitation to buy or sell any security. This is an anonymous forum for entertainment purposes only. Do not trust anything you read.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
